Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review.
Annalisa CespiatiInês Coelho RodriguesInês SantosSara PolicarpoSofia CarvalhanaAnna Ludovica FracanzaniHelena Cortez-PintoPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
Despite high heterogeneity and relatively short follow-up of included studies, we can conclude that the presence of metabolic risk factors should be strictly evaluated due to their impact on liver steatosis, glucidic and lipid homeostasis, and on weight gain to better identify patients at risk of liver disease progression despite the virus eradication.